FERRANNINI, ELEUTERIO
 Distribuzione geografica
Continente #
NA - Nord America 33.051
EU - Europa 13.174
AS - Asia 4.833
AF - Africa 152
SA - Sud America 60
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 14
Totale 51.332
Nazione #
US - Stati Uniti d'America 32.050
IT - Italia 4.694
CN - Cina 2.968
SE - Svezia 2.309
BG - Bulgaria 1.701
UA - Ucraina 1.100
CA - Canada 983
DE - Germania 870
TR - Turchia 808
GB - Regno Unito 709
FI - Finlandia 707
VN - Vietnam 627
CH - Svizzera 476
HK - Hong Kong 173
RU - Federazione Russa 171
FR - Francia 124
IN - India 88
CI - Costa d'Avorio 79
BE - Belgio 77
SG - Singapore 52
AT - Austria 50
SN - Senegal 48
BR - Brasile 42
NL - Olanda 38
AU - Australia 37
GR - Grecia 28
PL - Polonia 27
ES - Italia 24
JP - Giappone 20
KR - Corea 20
IE - Irlanda 15
EU - Europa 14
MX - Messico 14
RO - Romania 13
IL - Israele 12
NZ - Nuova Zelanda 11
CZ - Repubblica Ceca 10
EG - Egitto 9
IQ - Iraq 6
NG - Nigeria 6
PK - Pakistan 6
PT - Portogallo 6
AR - Argentina 5
CO - Colombia 5
DK - Danimarca 5
HU - Ungheria 5
ID - Indonesia 5
TH - Thailandia 5
BD - Bangladesh 4
MA - Marocco 4
PH - Filippine 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
EE - Estonia 3
JO - Giordania 3
MY - Malesia 3
OM - Oman 3
TW - Taiwan 3
AM - Armenia 2
BN - Brunei Darussalam 2
CL - Cile 2
EC - Ecuador 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NO - Norvegia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
BS - Bahamas 1
CM - Camerun 1
CY - Cipro 1
DZ - Algeria 1
GH - Ghana 1
KH - Cambogia 1
KW - Kuwait 1
LT - Lituania 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
PE - Perù 1
SD - Sudan 1
UY - Uruguay 1
Totale 51.332
Città #
Fairfield 4.810
Woodbridge 3.444
Chandler 2.579
Ann Arbor 2.342
Ashburn 2.327
Houston 2.262
Milan 2.055
Seattle 1.926
Sofia 1.700
Cambridge 1.593
Wilmington 1.591
Jacksonville 1.513
Beijing 1.036
Ottawa 954
New York 899
Izmir 755
Serra 693
Princeton 688
Lawrence 637
Nanjing 614
Medford 606
Bern 461
Des Moines 424
Dearborn 264
Jüchen 257
Nanchang 253
San Diego 227
Dong Ket 222
Falls Church 170
Hong Kong 161
Kunming 148
Rome 146
Shenyang 128
Hebei 115
Boulder 113
London 98
Tianjin 94
Redwood City 92
Jiaxing 83
Changsha 80
Abidjan 79
Ogden 76
Brussels 71
Norwalk 71
Florence 69
Lancaster 68
Washington 66
Boardman 65
Los Angeles 63
Frankfurt am Main 58
Hefei 56
Orange 48
Pisa 48
Dakar 47
Pune 47
Hangzhou 46
Vienna 44
Auburn Hills 39
Verona 36
Jinan 35
Shanghai 33
Changchun 31
Chicago 29
Indiana 29
Zhengzhou 28
Guangzhou 27
Düsseldorf 26
Ningbo 26
Lanzhou 25
Warsaw 24
Kocaeli 23
Istanbul 22
San Francisco 19
Tappahannock 18
Bremen 17
Enterprise 16
Council Bluffs 15
Detroit 15
São Paulo 15
Edinburgh 14
Redmond 13
Chengdu 12
Helsinki 12
Simi Valley 12
Taizhou 12
Walnut 12
Nürnberg 11
Phoenix 11
Tokyo 10
Toronto 10
Xian 10
Zurich 10
Dublin 9
Sydney 9
Valencia 9
Amsterdam 8
Central District 8
Groningen 8
Kent 8
Fuzhou 7
Totale 40.345
Nome #
Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus 254
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 185
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance 160
Recombinant human TSH reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma 148
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study 148
Adipocyte P2X(7) receptors expression: A role in modulating inflammatory response in subjects with metabolic syndrome? 148
EFFECT OF FATTY-ACIDS ON GLUCOSE-PRODUCTION AND UTILIZATION IN MAN 145
THE THEORETICAL BASES OF INDIRECT CALORIMETRY - A REVIEW 145
Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. 141
[C-11]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia 138
ADRENERGIC-BLOCKADE ALTERS GLUCOSE KINETICS DURING EXERCISE IN INSULIN-DEPENDENT DIABETICS 135
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 135
LACK OF EFFECT OF PARATHYROID-HORMONE ON HEPATIC GLUCOSE-METABOLISM IN THE DOG 134
SPLANCHNIC AMINO-ACID AND GLUCOSE-METABOLISM DURING AMINO-ACID INFUSION IN DOGS 134
INSULIN RESISTANCE, INSULIN DEFICIENCY AND THE PATHOGENESIS OF DIABETES-MELLITUS 134
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects 134
null 134
Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure. 133
Relationship between impaired glucose tolerance, noninsulin-dependent diabetes mellitus and obesity 133
Adiponectin and left ventricular structure and function in healthy adults 132
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects 132
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance 131
Effects of insulin on the kidney and the cardiovascular system 131
Insulin resistance and hyperinsulinemia - No independent relation to left ventricular mass in humans 131
alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population 131
Differential effect of weight loss on insulin resistance in surgically treated obese patients 130
Beta-cell function in obesity: effects of weight loss 130
Rosiglitazone increases matrix production and quenches inflammation: studies in human cells 130
PARENTAL HISTORY OF DIABETES IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK-FACTORS 129
Insulin: new roles for an ancient hormone 129
Long-term follow-up of 106 multiple sclerosis patients undergoing IFN-ß 1a or 1b therapy: predictive factors of thyroid disease development and duration 128
REGULATION OF SPLANCHNIC AND PERIPHERAL GLUCOSE-UPTAKE BY INSULIN AND HYPERGLYCEMIA IN MAN 127
SODIUM ELEVATES THE PLASMA-GLUCOSE RESPONSE TO GLUCOSE-INGESTION IN MAN 126
EFFECT OF INSULIN AND GLUCOSE ON FEEDING-BEHAVIOR 125
INTERNAL BILIARY DIVERSION IMPROVES GLUCOSE-TOLERANCE IN THE RAT 125
RESPONSE TO INTRAVENOUS GLUCOSE OF PATIENTS ON MAINTENANCE HEMODIALYSIS - EFFECTS OF DIALYSIS 124
HEPATIC AND PERIPHERAL INSULIN RESISTANCE - A COMMON FEATURE OF TYPE-2 (NON-INSULIN-DEPENDENT) AND TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS 124
INSULIN ACTION AND SUBSTRATE COMPETITION 124
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 124
MECHANISM OF IMPROVEMENT IN GLUCOSE-METABOLISM AFTER CHRONIC GLYBURIDE THERAPY 123
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis 123
Daylong pituitary hormones in morbid obesity: effects of bariatric surgery 123
PATTERN OF INSULIN DELIVERY AFTER INTRAVENOUS GLUCOSE INJECTION IN MAN AND ITS RELATION TO PLASMA-GLUCOSE DISAPPEARANCE 122
Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function 122
Quantification of liver glucose metabolism by positron emission tomography: Validation study in pigs 122
ACUTE RESPIRATORY-DISTRESS SYNDROME IN AN ADULT PATIENT WITH A MYELODYSPLASTIC DISORDER 121
THE PATHOGENESIS OF NON-INSULIN-DEPENDENT DIABETES 121
HEPATIC AND EXTRAHEPATIC SPLANCHNIC GLUCOSE-METABOLISM IN THE POSTABSORPTIVE AND GLUCOSE FED DOG 121
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects 121
THE RELATIONSHIP OF PLASMA CATECHOLAMINE AND LACTATE DURING ANAEROBIC THRESHOLD EXERCISE IN MITOCHONDRIAL MYOPATHIES 121
Effect of acute hyperglycemia on insulin secretion in humans 120
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. 120
Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. 120
Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E β-cells. 120
THE DISPOSAL OF AN ORAL GLUCOSE-LOAD IN HEALTHY-SUBJECTS - A QUANTITATIVE STUDY 119
IMPAIRED INSULIN DEGRADATION IN A PATIENT WITH INSULIN RESISTANCE AND ACANTHOSIS NIGRICANS 119
TIME-DEPENDENCE OF THE INTERACTION BETWEEN LIPID AND GLUCOSE IN HUMANS 119
DIFFERENTIAL-EFFECTS OF INSULIN AND HYPERGLYCEMIA ON INTRACELLULAR GLUCOSE DISPOSITION IN HUMANS 119
Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes 119
Physical activity and insulin sensitivity - the RISC Study 119
Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T-4 replacement therapy 119
Effect of 1-year treatment with interferon-beta 1b on thyroid function and autoimmunity in patients with multiple sclerosis 119
A MODEL OF GLUCOSE KINETICS AND THEIR CONTROL BY INSULIN, COMPARTMENTAL AND NONCOMPARTMENTAL APPROACHES 118
OPERATION OF RANDLES CYCLE IN PATIENTS WITH NIDDM 118
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects 118
TRANSIENT HEPATIC RESPONSE TO GLUCAGON IN MAN - ROLE OF INSULIN AND HYPERGLYCEMIA 117
Endothelial dysfunction in type 2 diabetes 117
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 117
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 116
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 116
EFFECTS OF PHYSIOLOGICAL PLASMA-INSULIN LEVELS ON GLUCOSE-TURNOVER PARAMETERS IN FAMILIAL HYPERCHOLESTEROLEMIA 115
Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control 115
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: An endocrine society clinical practice guideline 115
Quantification of liver perfusion with [(15)O]H(2)O-PET and its relationship with glucose metabolism and substrate levels 115
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 115
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients 114
ACUTE ELEVATION OF FREE FATTY-ACID LEVELS LEADS TO HEPATIC INSULIN RESISTANCE IN OBESE SUBJECTS 113
RELATION OF BIRTH-WEIGHT TO MATERNAL PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS DURING NORMAL-PREGNANCY 113
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects 113
METABOLIC EFFECTS OF LOW-DOSE INSULIN THERAPY ON GLUCOSE-METABOLISM IN DIABETIC-KETOACIDOSIS 112
Hypertension, insulin resistance, and diabetes 112
Of mighty mice and diabetic men: animal models of islet dysfunction 112
Consensus statement on the worldwide standardization of the hemoglobin A1C measurement - The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation 112
Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes. 112
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans 112
INFLUENCE OF LONG-TERM DIABETES ON LIVER-GLYCOGEN METABOLISM IN THE RAT 111
INSULIN-RESISTANCE AND INSULIN DEFICIENCY IN THE PATHOGENESIS OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS - ERRORS OF METABOLISM OR OF METHODS 111
Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism 111
THYROID AUTOIMMUNITY AND DYSFUNCTION ASSOCIATED WITH TYPE I INTERFERON THERAPY 110
The effect of rosiglitazone on the liver: Decreased gluconeogenesis in patients with type 2 diabetes 110
Determinants of postabsorptive endogenous glucose output in non-diabetic subjects 110
Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man 110
Skin Vasodilator Function and Vasomotion in Patients with Morbid Obesity: Effects of Gastric Bypass Surgery 110
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 110
SYNERGISTIC INTERACTION BETWEEN EXERCISE AND INSULIN ON PERIPHERAL GLUCOSE-UPTAKE 109
CLUSTERING OF CARDIOVASCULAR RISK-FACTORS IN CONFIRMED PREHYPERTENSIVE INDIVIDUALS 109
Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration, in NIDDM patients 109
F-18-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: A validation study 109
Effect of a fatty meal on inflammatory markers in healthy volunteers with a family history of type 2 diabetes 109
Personalized Management in Type 2 Diabetes 109
Totale 12.437
Categoria #
all - tutte 131.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.454 0 0 0 0 0 0 0 0 0 0 1.863 1.591
2019/202012.181 1.469 1.061 651 809 1.265 1.230 1.415 1.050 1.388 727 900 216
2020/20215.384 562 327 535 201 576 224 340 608 370 538 271 832
2021/20226.934 99 373 166 484 1.408 1.005 138 355 396 210 314 1.986
2022/20236.552 924 646 329 632 870 1.017 59 514 1.061 56 374 70
2023/20245.969 1.153 888 905 486 1.030 1.012 49 234 121 71 20 0
Totale 51.993